Pulmonary edema diagnostic study of choice
Jump to navigation
Jump to search
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farnaz Khalighinejad, MD [2]
Pulmonary edema Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pulmonary edema diagnostic study of choice On the Web |
Risk calculators and risk factors for Pulmonary edema diagnostic study of choice |
Overview
Pulmonary artery catheterization is the gold standard test for the diagnosis of pulmonary edema. Elevated pulmonary-artery pressure indicates cardiogenic pulmonary edema or pulmonary edema due to volume overload.
Diagnostic study of choice
Pulmonary-Artery Catheterization
Pulmonary artery catheterization is the gold standard test for the diagnosis of pulmonary edema.[1][2]
- Insertion of a pulmonary arterial catheter (a.k.a. a Swan-Ganz catheter) to distinguish between the two main forms of pulmonary edema and to help guide management.
- In patients with cardiogenic pulmonary edema the pulmonary artery pressure will be elevated.
- Among patients with non-cardiogenic pulmonary edema the wedge pressure will not be elevated.
- Pulmonary artery catheterization is commonly used in ICU patients with severe acute decompensated CHF.
- Studies showed no improvement in mortality rate or decrease in the number of hospitalization in patients who underwent pulmonary artery catheterization.[3]
References
- ↑ Swan HJ, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D (August 1970). "Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter". N. Engl. J. Med. 283 (9): 447–51. doi:10.1056/NEJM197008272830902. PMID 5434111.
- ↑ Ware LB, Matthay MA (December 2005). "Clinical practice. Acute pulmonary edema". N. Engl. J. Med. 353 (26): 2788–96. doi:10.1056/NEJMcp052699. PMID 16382065.
- ↑ Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW (October 2005). "Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial". JAMA. 294 (13): 1625–33. doi:10.1001/jama.294.13.1625. PMID 16204662.